Celebrex and Bronchitis chronic - a phase IV clinical study of FDA data

Summary:

Bronchitis chronic is reported as a side effect among people who take Celebrex (celecoxib), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Fosamax, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Bronchitis chronic when taking Celebrex. It is created by eHealthMe based on reports of 147,540 people who have side effects when taking Celebrex from the FDA, and is updated regularly.

What is Celebrex?

Celebrex has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 151,106 Celebrex users. Check the latest studies of Celebrex.

What is Bronchitis chronic?

Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic) is found to be associated with 566 drugs and 543 conditions by eHealthMe. Check the latest studies of Bronchitis chronic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

147,540 people reported to have side effects when taking Celebrex.
Among them, 71 people (0.05%) have Bronchitis chronic.

Could Celebrex cause Bronchitis chronic?

Among these 71 people:

How long have people been on Celebrex when they have Bronchitis chronic? *

What is the gender of people who have Bronchitis chronic when taking Celebrex? *

female: 88.73 %
male: 11.27 %

What is the age of people who have Bronchitis chronic when taking Celebrex? *

What are other drugs people take besides Celebrex? *

What are other side effects people have besides Bronchitis chronic? *

Joint Pain: 34 people, 47.89%
High Blood Pressure: 28 people, 39.44%
Fall: 24 people, 33.80%
Head Injury: 22 people, 30.99%
Fatigue (feeling of tiredness): 21 people, 29.58%
Urinary Tract Infection: 18 people, 25.35%
Back Pain: 17 people, 23.94%
Dizziness: 17 people, 23.94%
Pain In Extremity: 17 people, 23.94%
Weakness: 16 people, 22.54%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 20 people, 28.17%
Osteoporosis (bones weak and more likely to break): 10 people, 14.08%
Sleep Disorder: 6 people, 8.45%
Hypersensitivity: 6 people, 8.45%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 8.45%
Osteopenia (a condition where bone mineral density is lower than normal): 5 people, 7.04%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 5 people, 7.04%
High Blood Pressure: 5 people, 7.04%
Psoriasis (immune-mediated disease that affects the skin): 5 people, 7.04%
Joint Pain: 4 people, 5.63%

* Approximation only. Some reports may have incomplete information.

Do you take Celebrex and have Bronchitis chronic?

- Check whether Bronchitis chronic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Celebrex:

Celebrex (151,106 reports)

Browse all side effects of Celebrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchitis chronic:

Bronchitis chronic (566 drugs)

Browse all the conditions that are associated with Bronchitis chronic:

Bronchitis chronic (543 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on celecoxib (the active ingredients of Celebrex) and Celebrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.